Session Information
2008 BIO International Convention
Click here to go to the previous page
Is Biomanufacturing the Next Product-Enabling Technology?
Track : Manufacturing
Program Code: 1350
Date: Friday, June 20, 2008
Time: 9:00 AM to 10:30 AM  EST
Location: 29B
CHAIR :
Robert Tenerowicz, MBA, VP, Operations , XOMA, Ltd
SPEAKER (S):
Dr. Marco Cacciuttolo, CEO , PERCIVIA
John Cox, PhD, Senior Vice President, Global Manufacturing , Biogen Idec, Inc
Parrish Galliher, MS, President, Founder & CTO , Xcellerex, Inc
Ashley Lawton, PhD, VP of Business Development , GTC Biotherapeutics, Inc
Hubert Scoble, Wyeth
Description
"Since its inception, the biotechnology industry has depended on new technologies for the discovery and development of products. Manufacturing, although essential, has been positioned as a step in the commercialization process. With rapid growth in the number of biopharmaceutical products on the market and the advent of follow-on biologics, however, manufacturing is becoming a strategic, enabling technology that is allowing innovative companies with high-efficiency expertise to participate in product development. This panel will look at a number of companies that are leveraging unique manufacturing expertise to develop biopharmaceuticals and their product development strategies."

Objective1:Explore how biotech manufacturing has become a productenabling technology.

Objective2:Examine how manufacturing has become an integral part of product development.

Objective3:Explain how to leverage manufacturing expertise as a competitive advantage.


Streaming Audio with
PowerPoint Slides
(Code: 1350)
  
This session is a part of: